Pretraživanje
Prikaz rezultata 1-10 od 42
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
Expression analysis of jak-stat dependent s100 calcium binding proteins a4 and a12 in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2013)
Cd38 and interleukin 6 gene polymorphism in b-cell chronic lymphocytic leukemia-correlation with clinical and laboratory parametars
(Ferrata Storti Foundation, Pavia, 2016)
Imageability ratings across languages
(Springer, New York, 2018)
Imageability is a psycholinguistic variable that indicates how well a word gives rise to a mental image or sensory experience. Imageability ratings are used extensively in psycholinguistic, neuropsychological, and ...
Hypoxia inducible genes, erythropoietin and vascular endothelial growth factor expression in renal cell carcinoma
(Ferrata Storti Foundation, Pavia, 2013)
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
(Amer Soc Hematology, Washington, 2019)
Increased energy requirement and metabolic reprogramming are hallmarks of cancer cells. We show that metabolic alterations in hematopoietic cells are fundamental to the pathogenesis of mutant JAK2-driven myeloproliferative ...
Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2017)
Predictors of survival in patients with essential thrombocythemia
(Ferrata Storti Foundation, Pavia, 2015)
Transcriptional profiling of human erythroid progenitors from g-csf mobilized and nonmobilized peripheral blood
(Ferrata Storti Foundation, Pavia, 2013)